1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M


1 Year 1Y

5 Years 5Y

About Dexcom Inc

DexCom, Inc. empowers people to take control of diabetes through innovative continuous glucose monitoring (CGM) products. Headquartered in San Diego, California, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of patients, caregivers, and clinicians, Dexcom simplifies and improves diabetes management around the world.
Kevin Sayer

6340 Sequence Dr
San Diego, California 92121-4356
Phone: 18582000200


Dexcom Leads 5 Stocks Near Buy Points
Nov 25, 2022 12:45pm

Dexcom and other top stocks to watch this week combine strong technicals with generally solid fundamentals.

Source:Investor''s Business Daily
CES 2023 robotics Innovation Award winners announced
Nov 22, 2022 00:00am

A quick look at the 2023 CES Innovation award winners in the robotics category covers a broad range of solutions that impact consumers.

Compact Chainflex control cables guarantee 100 million cycles
Nov 22, 2022 00:00am

igus is continuously improving to optimize customers’ moving applications. The specialist for moving cables has now refined its successful chainflex control cable series. The CF98.PLUS and CF99.PLUS are the only cables on the market that are guaranteed to handle over 100 million cycles or that can be used in energy chains with tiny bend radii […]

Sheetz Drops Gas Prices for Unleaded 88
Nov 21, 2022 00:00am

Sheetz announced it will kick off the holiday season by reducing the price of Unleaded 88 to $1.99 a gallon. This limited-time promotion began on Monday, Nov. 21 and will last through Nov. 28, 2022. “Sheetz is a family-owned and -operated company, and at the heart of everything we do is giving back to our…

Top 5 3rd Quarter Trades of Alphabet Inc.
Nov 17, 2022 02:00am

Related Stocks: IONQ , RCUS , GTLB , VLD , DXCM ,

Dexcom Invites the Diabetes Community to #seediabetes This November and Share Their Diabetes Story With Custom Continuous Glucose Monitor (CGM) Patches
Nov 14, 2022 09:00am

DexCom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring, its global partners and Dexcom Warriors will once again help the world #SeeDiabetes and empower members of the diabetes community to express their unique journey with diabetes in an accessible way – by creating custom Dexcom CGM patches via the newly launched design site that illustrate just how unique each

2 Reasons to Buy DexCom, and 1 Reason to Sell
Nov 07, 2022 14:45pm

Do the potential benefits outweigh the risks?

Source:The Motley Fool
New Insight On DexCom Inc. (DXCM)
Nov 04, 2022 16:00pm

DexCom Inc. (NASDAQ:DXCM) at last check was buoying at $115.40 on Friday, November 04, with a rise of 2.49% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $112.60 and 5Y monthly beta was reading 1.04 with its price kept floating in … New Insight On DexCom Inc. (DXCM) Read More »

Source:Stocks Register
Is It Too Late to Buy DexCom Stock? | The Motley Fool
Nov 04, 2022 12:45pm

The shares have been surging after the medical device specialist released its latest earnings report.

Source:The Motley Fool
DexCom: After Q3, A Strong Competitive Advantage With Secular Tailwinds (NASDAQ:DXCM)
Nov 02, 2022 21:16pm

DexCom had an excellent Q3, beating expectations and revising guidance. Market for diabetes remains large and growing, benefiting DexCom and its new G7 product. Read more here.

Source:Seeking Alpha
Do you want to know where to find good stock? Take a look at DexCom Inc.’s (NASDAQ:DXCM) Sentiment Analysis
Nov 02, 2022 17:32pm

In the current trading session, DexCom Inc.’s (DXCM) stock is trading at the price of $119.19, a gain of 0.13% over last night’s close. So, the stock is trading at a price that is -27.70% less than its 52-week high of $164.86 and 78.19% better than its 52-week low of $66.89. Based on the past […]

Source:US Post News
DexCom''s Return On Capital Employed Insights
Nov 02, 2022 14:21pm

According to Benzinga Pro, during Q3, DexCom (NASDAQ: DXCM ) earned $101.20 million, a 98.82% increase from the preceding quarter. DexCom also posted a total of $769.60 million in sales, a 11.18% increase since Q2. DexCom earned $50.90 million, and sales totaled $692.20 million in Q2. What Is ROCE? Earnings data without context is not clear and can be difficult to base trading decisions on. Return on Capital Employed (ROCE) helps to filter signal from noise by measuring yearly pre-tax profit relative to capital employed by a business. Generally, a higher ROCE suggests successful growth … Full story available on Benzinga.com

Is DexCom a Good Healthcare Stock to Buy Now?
Nov 02, 2022 09:31am

After rising about 50% in October, investors want to know if this stock still has any fuel in the tank.

Source:The Motley Fool
DexCom Inc. Is A Buy Small Cap Stock: Analysts
Nov 01, 2022 19:00pm

DexCom Inc. (NASDAQ:DXCM) has a beta value of 1.09 and has seen 0.71 million shares traded in the recent trading session. The company, currently valued at $39.72B, closed the recent trade at $118.81 per share which meant it lost -$1.97 on the day or -1.64% during that session. The DXCM stock price is -38.76% off … DexCom Inc. Is A Buy Small Cap Stock: Analysts Read More »

Source:Marketing Sentinel
Dexcom Partners With Warriors and Nonprofits to Artfully Advocate for Access to Diabetes Care
Nov 01, 2022 13:00pm

SAN DIEGO--(BUSINESS WIRE)---- $DXCM #CGM--Dexcom partners with Warriors and nonprofits to artfully advocate for access to diabetes care

Source:Business Wire
Glucose monitoring device maker DexCom stock rallies more than 50% in October to pace the S&P 500
Oct 31, 2022 15:57pm

keep them on track to be the S&P 500''s undefined best October performer with a month-to-date gain of 50.6%. The rally comes as maker of glucose monitoring…

Why Pinterest Shares Jumped Around 14%; Here Are 69 Biggest Movers From Friday
Oct 31, 2022 08:13am

Gainers Quanergy Systems, Inc. (NASDAQ: QNGY ) jumped 153.9% to close at $3.30 on Friday. Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE ) surged 61.4% to close at $0.92 after jumping 15% on Thursday. Nuvalent, Inc. (NASDAQ: NUVL ) shares gained 60.6% to close at $35.34 after the company reported preliminary Phase 1 clinical data from the ARROS-1 trial that support the best-in-class potential of NVL-520 for patients with ROS1-positive NSCLC. Bull Horn Holdings Corp. (NASDAQ: BHSE ) jumped 44.7% to close at $11.95. Fangdd Network Group Ltd. (NASDAQ: DUO ) gained 36.6% to close at $1.94. Provident Acquisition Corp. (NASDAQ: PAQC ) shares jumped 32.7% to close at $11.00. Perfect Corp. and Provident Acquisition Corp. recently announced approval of business combination by Provident''s shareholders. Rail Vision Ltd. (NASDAQ: RVSN ) gained 27.9% to close at $0.7675. Sierra Metals Inc. (NYSE: SMTS ) climbed 27.8% to close at $0.2128. Sierra Metals'' largest shareholder and Compañia Minera Kolpa announced Letter of Intent for Sierra Metals transaction and financing.

DexCom Stock: Bull vs. Bear
Oct 30, 2022 13:02pm

The diabetes care technology leader has a huge opportunity. But its valuation could be an issue.

Source:The Motley Fool
Hot Stocks: AMZN, EW drop on earnings; DXCM, GILD surge
Oct 28, 2022 22:07pm

AMZN and EW dropped following their quarterly reports. DXCM and GILD rallied on their own financial figures.

Source:Seeking Alpha
DXCM stock hits six-month high after Q3 beat (NASDAQ:DXCM)
Oct 28, 2022 18:01pm

DexCom (DXCM) climbed ~16% intraday Friday to reach the highest level since April after the medical device maker posted better-than-expected financials for Q3 2022, drawing favorable…

Source:Seeking Alpha
Dexcom Stock Soars on Earnings and Revenue Beat
Oct 28, 2022 16:59pm

The maker of glucose monitoring systems beats third-quarter earnings and revenue expectations.

Why DexCom Stock Is Soaring Today
Oct 28, 2022 15:59pm

Investors loved the company''s third-quarter update.

Source:The Motley Fool
Nuvalent, DexCom top healthcare gainers; DaVita, LeMaitre lead losers'' pack
Oct 28, 2022 14:02pm

Nuvalent NUVL +71%. DexCom (DXCM) +14%. DaVita DVA -23%. LeMaitre Vascular (LMAT) -16%.

Source:Seeking Alpha
DexCom PT Raised to $114 at Cowen
Oct 28, 2022 08:20am


DexCom (DXCM) Q3 2022 Earnings Call Transcript
Oct 28, 2022 02:01am

DXCM earnings call for the period ending September 30, 2022.

Source:The Motley Fool
DexCom, Inc. (DXCM) Q3 2022 Earnings Call Transcript
Oct 27, 2022 23:28pm

DexCom, Inc. (NASDAQ:NASDAQ:DXCM) Q3 2022 Earnings Conference Call October 27, 2022, 04:30 PM ET Company Participants Sean Christensen - IR Kevin Sayer - Chairman, President and CEO Jereme…

Source:Seeking Alpha
DLO, MPWR and SLNA are among after hour movers
Oct 27, 2022 22:03pm

Gainers: JAKKS Pacific (JAKK) +16%. DexCom (DXCM) +8%

Source:Seeking Alpha
Today’s watch list includes DexCom Inc. (NASDAQ:DXCM) stock
Oct 27, 2022 16:48pm

Currently, DexCom Inc.’s (DXCM) stock is trading at $100.76, marking a fall of -1.80% from last night’s close. At this price, the stock is -38.88% below its 52-week high of $164.86 and 50.63% above its 52-week low of $66.89. Based on the past 30-day period, the stock price is -4.06% below the high and +25.75% […]

Source:US Post News
$1000 Invested In This Stock 10 Years Ago Would Be Worth $31,000 Today
Oct 27, 2022 15:07pm

DexCom (NASDAQ: DXCM ) has outperformed the market over the past 10 years by 30.49% on an annualized basis producing an average annual return of 40.98%. Currently, DexCom has a market capitalization of $39.56 billion. Buying $1000 In DXCM: If an investor … Full story available on Benzinga.com

What Does 2022 Hold For DexCom Inc. (NASDAQ:DXCM)?
Oct 21, 2022 18:00pm

DexCom Inc. (NASDAQ:DXCM) price on Friday, October 21, fall -1.53% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $92.92. A look at the stock’s price movement, the level at last check in today’s session was $94.36, moving within a range at $93.79 and $97.45. The beta value … What Does 2022 Hold For DexCom Inc. (NASDAQ:DXCM)? Read More »

Source:Stocks Register
Jefferies Starts DexCom at Buy
Oct 11, 2022 21:15pm


Why DexCom Stock Popped on Friday, Even as the Market Crumbled
Oct 07, 2022 23:12pm

The medical device maker could benefit from a pending decision by Medicare that could be a game changer.

Source:The Motley Fool
DexCom Up After Medicare Proposal Looking at Covering CGMs
Oct 07, 2022 14:38pm

Shares of DexCom (NASDAQ: DXCM) were up in morning trading on Friday after the Centers for Medicare and Medicaid Services (SMC) issued a proposal to determine local coverage related to continuous glucose monitoring (CGM) devices. This proposal could stand to benefit DexCom as the company is focused on developing, manufacturing, and producing continuous glucose monitoring systems for diabetes management. Is DexCom a Good Stock to Buy? Wall Street analysts remain bullish about DexCom with a Strong Buy consensus rating based on 13 Buys and one Hold. The average price target for DXCM stock is $99.77 with a downside potential of 3.

DexCom Surges as CGM Market Could be Doubled on New Medicare Proposal
Oct 07, 2022 14:11pm


DXCM stock gains as Medicare updates coverage for glucose monitoring (NASDAQ:DXCM)
Oct 07, 2022 13:07pm

DexCom (DXCM) shares jumped ~10% in the pre-market trading Friday after the Centers for Medicare and Medicaid Services ((SMC)) issued a proposed local coverage determination related…

Source:Seeking Alpha
DXCM, BYFC and IVA are among pre market gainers
Oct 07, 2022 12:54pm

Innovative Eyewear (LUCY) +88%. Ambac Financial Group (AMBC) +21% Settles RMBS Litigations Against Bank of America.Inventiva (IVA) +15%

Source:Seeking Alpha
William Blair Positive on DexCom , Abbott on Doubling of CGM Market TAM
Oct 07, 2022 12:45pm


Do investors need to be concerned about DexCom Inc. (DXCM)?
Oct 06, 2022 15:00pm

The share price of DexCom Inc. (NASDAQ:DXCM) rose to $91.08 per share on Wednesday from $90.97. While DexCom Inc. has overperformed by 0.12%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, DXCM fell by -32.58%, with highs and lows ranging from $164.86 to $66.89, whereas the […]

Source:US Post News
Why DexCom Was Such a Healthy Stock Today
Oct 04, 2022 21:01pm

The company had some encouraging news to report about its international sales effort.

Source:The Motley Fool
DexCom Launches G7 System in Key Markets Across Europe and Asia
Oct 04, 2022 10:41am

Medical devices provider DexCom (NASDAQ:DXCM) has launched its continuous glucose monitoring system DexCom G7 across the U.K., Ireland, Germany, Austria, and Hong Kong. DXCM also plans to introduce the product in New Zealand and South Africa in the coming weeks. The device sends real-time glucose data to a receiver without the need for finger sticks or scanning. Further, the company is also working with insulin pump partners to integrate the device with present and future automatic insulin delivery systems.

Dexcom launches G7 glucose monitoring system in parts of Europe, Asia
Oct 04, 2022 08:52am

DexCom (DXCM) said its Dexcom G7 Continuous Glucose Monitoring ((CGM)) system was now available for people with diabetes age two years and older in the U.K., Ireland, Germany, Austria…

Source:Seeking Alpha
DexCom, Inc.: Dexcom G7 Launches in the United Kingdom, Ireland, Germany, Austria and Hong Kong - Initiating Global Rollout of World''s Most Powerful Continuous Glucose Monitoring System
Oct 04, 2022 07:03am

People with diabetes in the United Kingdom, Ireland, Germany, Austria and Hong Kong can get started with Dexcom G7 now The new CGM system is also expected to launch in New Zealand and South Africa…

Source:Finanz Nachrichten
Dexcom G7 Launches in the United Kingdom, Ireland, Germany, Austria and Hong Kong – Initiating Global Rollout of World’s Most Powerful Continuous Glucose Monitoring System
Oct 04, 2022 07:00am

DexCom, Inc. (Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today the Dexcom G7 Continuous Glucose Monitoring (CGM) System is now available for people with diabetes age two years and older in the UK, Ireland, Germany, Austria and Hong Kong – marking the first major milestone in the availability of the revolutionary new technology.

Dexcom Schedules Third Quarter 2022 Earnings Release and Conference Call for October 27, 2022 at 4:30 p.m. Eastern Time.
Sep 29, 2022 13:00pm

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its third quarter 2022 financial results after market close on Thursday, October 27, 2022. Management will hold a conference call to review the company''s third quarter 2022 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the Dexcom investor relations website at investors.dexcom.com and wil

Source:Business Wire